82
77
Growth Score 82 in past quarter
-6 pts
Heat Score 77 in past quarter
0 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
1539588
GentleMed creates the AccuEye to meet patient.
About the Company
GentleMed creates the AccuEye to meet patient.
What if you were one of the 60 Million people going blind because of Glaucoma? The precision of each drop is the difference between blindness and sight. In the U.S. alone, the glaucoma treatment market is worth $2.9 billion. Eye drops are easy to forget and difficult to apply. They have created the
AccuEye to meet patients needs. Their low risk, Class I device has easy entry into the market. If half of todays non-compliant patients become compliant with AccuEye, healthcare will save $1B each year